Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Elevated blood pressure in high-fat diet-exposed low birthweight rat offspring is most likely caused by elevated glucocorticoid levels due to abnormal pituitary negative feedback.

Tytuł:
Elevated blood pressure in high-fat diet-exposed low birthweight rat offspring is most likely caused by elevated glucocorticoid levels due to abnormal pituitary negative feedback.
Autorzy:
Nemoto T; Department of Bioregulatory Science (Physiology), Nippon Medical School, Tokyo, Japan.
Nakakura T; Department of Anatomy, Graduate School of Medicine, Teikyo University, Tokyo, Japan.
Kakinuma Y; Department of Bioregulatory Science (Physiology), Nippon Medical School, Tokyo, Japan.
Źródło:
PloS one [PLoS One] 2020 Aug 27; Vol. 15 (8), pp. e0238223. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
MeSH Terms:
Blood Pressure/*physiology
Feedback, Physiological/*physiology
Glucocorticoids/*blood
Pituitary Diseases/*blood
Pituitary Diseases/*physiopathology
Pituitary Gland/*physiology
Animals ; Birth Weight/drug effects ; Birth Weight/physiology ; Blood Pressure/drug effects ; Corticosterone/blood ; Diet, High-Fat/adverse effects ; Female ; Humans ; Hypertension/blood ; Hypertension/physiopathology ; Infant, Low Birth Weight/blood ; Infant, Low Birth Weight/physiology ; Infant, Newborn ; Male ; Metyrapone/therapeutic use ; Pituitary Diseases/drug therapy ; Pituitary Gland/drug effects ; Pregnancy ; Prenatal Exposure Delayed Effects/blood ; Prenatal Exposure Delayed Effects/physiopathology ; Rats ; Rats, Wistar
References:
Hypertension. 1998 Jul;32(1):78-83. (PMID: 9674641)
Endocr J. 2002 Aug;49(4):405-12. (PMID: 12402971)
J Dev Orig Health Dis. 2019 Feb;10(1):55-62. (PMID: 29366439)
Med Mol Morphol. 2016 Sep;49(3):133-43. (PMID: 26700226)
Br Heart J. 1995 Apr;73(4):363-7. (PMID: 7756071)
J Am Heart Assoc. 2019 Dec 3;8(23):e011911. (PMID: 31787052)
J Neurogastroenterol Motil. 2017 Jan 30;23(1):135-143. (PMID: 27829577)
Endocrinology. 2016 May;157(5):1799-812. (PMID: 27007071)
Pharmacol Ther. 2008 Dec;120(3):292-316. (PMID: 18804122)
Lancet. 1989 Sep 9;2(8663):577-80. (PMID: 2570282)
Atherosclerosis. 2014 Dec;237(2):391-9. (PMID: 25463063)
Semin Perinatol. 2010 Jun;34(3):188-92. (PMID: 20494734)
Exp Mol Med. 2020 Mar;52(3):473-484. (PMID: 32161397)
Br Med Bull. 2001;60:5-20. (PMID: 11809615)
Am J Physiol. 1999 Sep;277(3):F437-46. (PMID: 10484527)
Psychoneuroendocrinology. 2009 Jun;34(5):762-72. (PMID: 19167168)
Br J Pharmacol. 2003 Nov;140(5):809-24. (PMID: 14530223)
Reprod Sci. 2014 Apr;21(4):517-25. (PMID: 24023031)
J Dev Orig Health Dis. 2011 Jun;2(3):176-83. (PMID: 25141043)
Physiol Behav. 2000 Nov 1-15;71(3-4):353-62. (PMID: 11150568)
J Dev Orig Health Dis. 2018 Jun;9(3):315-328. (PMID: 29397052)
J Nutr. 1973 Jun;103(6):929-36. (PMID: 4705279)
Adv Exp Med Biol. 2009;646:51-8. (PMID: 19536662)
Nat Protoc. 2006;1(3):1559-82. (PMID: 17406449)
Can J Physiol Pharmacol. 2012 Mar;90(3):287-93. (PMID: 22364522)
J Endocrinol. 2015 Feb;224(2):195-203. (PMID: 25480379)
J Biol Chem. 1993 Nov 25;268(33):24543-6. (PMID: 8227011)
Sci Rep. 2019 Aug 22;9(1):12270. (PMID: 31439894)
Adv Exp Med Biol. 2018;1012:49-59. (PMID: 29956194)
FEBS Lett. 2002 Dec 18;532(3):379-86. (PMID: 12482596)
J Dev Orig Health Dis. 2010 Feb;1(1):6-18. (PMID: 25142928)
N Engl J Med. 1999 Jan 14;340(2):115-26. (PMID: 9887164)
J Perinat Med. 2012 Jan 06;40(3):287-96. (PMID: 22505508)
J Endocrinol. 2019 Aug;242(2):65-77. (PMID: 31117053)
Lancet. 2013 Jul 20;382(9888):273-83. (PMID: 23727166)
Lancet. 2002 Dec 14;360(9349):1903-13. (PMID: 12493255)
Curr Opin Nephrol Hypertens. 2009 Mar;18(2):144-52. (PMID: 19434052)
J Biol Chem. 1993 Nov 25;268(33):24539-42. (PMID: 8227010)
J Hypertens. 2000 Jul;18(7):815-31. (PMID: 10930178)
Methods Mol Biol. 2017;1614:69-73. (PMID: 28500596)
Clin Pediatr Endocrinol. 2010 Oct;19(4):83-90. (PMID: 23926383)
J Epidemiol Community Health. 2004 Feb;58(2):120-5. (PMID: 14729890)
Am J Hum Biol. 2007 Jan-Feb;19(1):1-19. (PMID: 17160980)
J Dev Orig Health Dis. 2018 Dec;9(6):598-614. (PMID: 30078383)
Pediatr Res. 2010 Aug;68(2):100-4. (PMID: 20453715)
Am J Physiol Endocrinol Metab. 2017 Feb 1;312(2):E98-E108. (PMID: 27965205)
Am J Obstet Gynecol. 2014 Sep;211(3):237.e1-237.e13. (PMID: 24631702)
Arch Intern Med. 1999 Jul 26;159(14):1607-12. (PMID: 10421284)
Acta Paediatr. 2019 Oct;108(10):1747-1756. (PMID: 30964948)
J Obstet Gynaecol Res. 2017 Jun;43(6):1001-1007. (PMID: 28503828)
Mol Endocrinol. 2013 Oct;27(10):1593-602. (PMID: 23893957)
Sci Rep. 2020 Jan 28;10(1):1339. (PMID: 31992823)
Clin Sci (Lond). 2008 Jan;114(1):1-17. (PMID: 18047465)
Am J Physiol Endocrinol Metab. 2012 Apr 1;302(7):E781-7. (PMID: 22252941)
Mol Neurobiol. 2020 Jan;57(1):551-565. (PMID: 31399953)
J Adolesc Health. 2011 May;48(5):520-2. (PMID: 21501813)
J Epidemiol Community Health. 2017 Oct;71(10):1014-1018. (PMID: 28822978)
J Physiol. 2014 Jun 1;592(11):2357-68. (PMID: 24882817)
Am J Hypertens. 2013 Jan;26(1):76-82. (PMID: 23382330)
Front Behav Neurosci. 2019 Aug 07;13:181. (PMID: 31440147)
Substance Nomenclature:
0 (Glucocorticoids)
W980KJ009P (Corticosterone)
ZS9KD92H6V (Metyrapone)
Entry Date(s):
Date Created: 20200828 Date Completed: 20201015 Latest Revision: 20201015
Update Code:
20240105
PubMed Central ID:
PMC7451543
DOI:
10.1371/journal.pone.0238223
PMID:
32853260
Czasopismo naukowe
Being delivered as a low birthweight (LBW) infant is a risk factor for elevated blood pressure and future problems with cardiovascular and cerebellar diseases. Although premature babies are reported to have low numbers of nephrons, some unclear questions remain about the mechanisms underlying elevated blood pressure in full-term LBW infants. We previously reported that glucocorticoids increased miR-449a expression, and increased miR-449a expression suppressed Crhr1 expression and caused negative glucocorticoid feedback. Therefore, we conducted this study to clarify the involvement of pituitary miR-449a in the increase in blood pressure caused by higher glucocorticoids in LBW rats. We generated a fetal low-carbohydrate and calorie-restricted model rat (60% of standard chow), and some individuals showed postnatal growth failure caused by growth hormone receptor expression. Using this model, we examined how a high-fat diet (lard-based 45kcal% fat)-induced mismatch between prenatal and postnatal environments could elevate blood pressure after growth. Although LBW rats fed standard chow had slightly higher blood pressure than control rats, their blood pressure was significantly higher than controls when exposed to a high-fat diet. Observation of glomeruli subjected to periodic acid methenamine silver (PAM) staining showed no difference in number or size. Aortic and cardiac angiotensin II receptor expression was altered with compensatory responses. Blood aldosterone levels were not different between control and LBW rats, but blood corticosterone levels were significantly higher in the latter with high-fat diet exposure. Administration of metyrapone, a steroid synthesis inhibitor, reduced blood pressure to levels comparable to controls. We showed that high-fat diet exposure causes impairment of the pituitary glucocorticoid negative feedback via miR-449a. These results clarify that LBW rats have increased blood pressure due to high glucocorticoid levels when they are exposed to a high-fat diet. These findings suggest a new therapeutic target for hypertension of LBW individuals.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies